| E |
|
EARLY DIAGNOSIS OF SEPTIC DISSEMINATED INTRAVASCULAR COAGULOPATHY
|
| Oh D., Jang M.M.J., Lee S.S.J., Chong S.S.Y., Kang M.M.S. |
| |
|
EARLY EXCLUSION OF MYOCARDIAL INFARCTION IN PATIENTS WITH CHEST PAIN BY TROPONIN I IN CONJUNCTION WITH D-DIMER
|
| Chang S., Chiu T., Ning H., Chen J. |
| |
|
EARLY F. XIII APPLICATION MAINTAINS CLOT FIRMNESS AND REDUCES BLOOD LOSS IN PATIENTS AT HIGH RISK FOR INCREASED INTRAOPERATIVE BLEEDING - EVIDENCE FROM A DOUBLE BLIND, PLACEBO CONTROLLED TRIAL
|
| Korte W.C., Gabi K., Gähler A., Kownacki E., Lange J., Schnider T. |
| |
|
EARLY HOME THERAPY AND OUTCOME AMONG 675 PATIENTS WITH PULMONARY EMBOLISM
|
| Olsson C., Linné R., Elf J., Jonson B., Bajc M. |
| |
|
EARLY INCREASE OF OXIDATIVE STRESS AND SOLUBLE CD40L IN CHILDREN
|
| Pignatelli P., Martino F., Martino E., Morrone F., Carnevale R., Di Santo S., Martini A., Loffredo L., Violi F. |
| |
|
EARLY SAFETY BENEFIT OF FONDAPARINUX VERSUS ENOXAPARIN IN PATIENTS WITH NON-ST ELEVATION ACUTE CORONARY SYNDROMES: A SECONDARY ANALYSIS OF THE OASIS-5 TRIAL
|
| Bassand J., Mehta S.R. |
| |
|
EARLY TISSUE FACTOR-INDUCED THROMBIN GENERATION IN PLATELETS: INFLUENCE OF ASPIRIN AND ASPIRIN PLUS CLOPIDOGREL
|
| Santos M.T., Piñon M., Lago A., Temble J., Dasi M., Fuset M., Moscardo A., Valles J. |
| |
|
EARLY VIRAL KINETICS PORTENDS THE LONG-TERM OUTCOME OF COMBINED THERAPY WITH PEGYLATED INTERFERON (PEG-IFN) PLUS RIBAVIRIN IN HEMOPHILIACS WITH HCV/HIV COINFECTION
|
| Mancuso M.E., Rumi M.G., Santagostino E., Soffredini R., Coppola A., Rocino A., Linari S., Colombo M., Mannucci P.M. |
| |
|
ECONOMIC BENEFITS OF KNEE SURGERY WITH RECOMBINANT ACTIVATED FACTOR VII IN HEMOPHILIA PATIENTS WITH INHIBITORS
|
| Botteman M.F., Ballal R., Joshi A. |
| |
|
ECONOMIC EVALUATION OF POINT-OF-CARE MONITORING DEVICES FOR LONG-TERM ORAL ANTICOAGULATION THERAPY
|
| Wells P.S., McGahan L., Cimon K., Jaffey J., Poon M., Brown A. |
| |
|
EDHIT: EVALUATION OF DERMATAN SULPHATE IN PREVENTION AND TREATMENT OF HEPARIN INDUCED THROMBOCYTOPENIA
|
| Filippucci E., Verso M., Ferrari G., Agnelli G. |
| |
|
EFFECT OF A FACTOR XA INHIBITOR DU-176B ON INTRACEREBRAL HEMORRHAGE IN RATS: A WIDER SAFETY MARGIN COMPARED WITH A THROMBIN INHIBITOR
|
| Morishima Y., Shirasaki Y., Kito F., Honda Y., Shibano T. |
| |
|
EFFECT OF AGE ON THE RELATIONSHIP BETWEEN RATE OF HEPARIN-CATALYZED INHIBITION OF COAGULATION FACTORS BY ANTITHROMBIN AND IN VIVO PLASMA CONCENTRATION
|
| Berry L.R., Patel S., Chan A.K.C. |
| |
|
EFFECT OF AGING ON PLASMINOGEN ACTIVATOR INHIBITOR-1 EXPRESSION IN RAT TISSUES. POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND CARDIOVASCULAR RISK
|
| Serrano R., Orbe J., Rodriguez J.A., Angos V., Montori L., Paramo J.A. |
| |
|
EFFECT OF ANTIDEPRESSANT DRUG TREATMENT ON INFLAMMATORY AND PLATELET ACTIVATION BIOMARKERS IN DEPRESSION
|
| Halaris A., Piletz J.E., Zhu H., Iqbal O., Hoppensteadt D., Fareed J. |
| |
|
EFFECT OF ANTIINFLAMMATORY DRUGS ON HUMAN NEUTROPHILS IN ENDOTHELIAL CELL DAMAGE INDUCED BY SHIGA TOXIN-1
|
| Landoni V.I., D'Atri L.P., Ramos M.V., Fernandez G., Rearte B., Laborde E., Palermo M., Schattner M., Isturiz M. |
| |
|
EFFECT OF ANTI-PLATELET DRUGS ON PLATELET AGGREGATION AND THROMBUS FORMATION INDUCED BY HUMAN ATHEROSCLEROTIC PLAQUES
|
| Penz S., Reininger A., Tóth O., Deckmyn H., Brandl R., Siess W. |
| |
|
EFFECT OF ATORVASTATIN ON MARKERS OF INFLAMMATION AND PLATELET AGGREGATION IN PATIENTS WITH CHRONIC HEART FAILURE
|
| Korzh O., Kotchuev G., Krasnokutskiy S. |
| |
|
EFFECT OF BIVALIRUDIN VS. BIVALIRUDIN WITH EPTIFIBATIDE ON PLATELET ACTIVATION AND AGGREGATION IN PATIENTS RECEIVING CHRONIC CLOPIDOGREL THERAPY UNDERGOING ELECTIVE PCI
|
| Gurbel P.A., Bliden K.P., DiChiara J., Antonino M., Gesheff T.B., Bailon O.V., Tantry U.S. |
| |
|
EFFECT OF BLOOD SALVAGE AND RE-INFUSION ON VTE COMPLICATIONS IN PATIENTS UNDERGOING ELECTIVE MAJOR ORTHOPEDIC SURGERY
|
| Filippucci E., Agnelli G., Gallus A., Anderson F.A., FitzGerald G. |
| |
|
EFFECT OF BOLUS TENECTEPLASE (TNK) ON RIGHT VENTRICULAR DYSFUNCTION IN NORMOTENSIVE PATIENTS WITH PULMONARY EMBOLISM: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
|
| Becattini C., Agnelli G., Salvi A., Grifoni S., Pancaldi L.G., Enea I., Balsemin F., Campanini M., Casazza F. |
| |
|
EFFECT OF CLOPIDOGREL TREATMENT ON STRESS-INDUCED PLATELET ACTIVATION AND MYOCARDIAL ISCHEMIA IN ASPIRIN-TREATED PATIENTS WITH STABLE CORONARY ARTERY DISEASE
|
| Perneby C., Wallén H.N., Hofman-Bang C., Tornvall P., Ivert T., Li N., Hjemdahl P. |
| |
|
EFFECT OF FACTOR XIII ON THE ANTI-FIBRINOLYTIC ACTIVITY OF THROMBIN-ACTIVATABLE FIBRINOLYSIS INHIBITOR (TAFI)
|
| Petersen L.C., Kjalke M. |
| |
|
EFFECT OF FIBRIN MATRICES ON INCREASED PROLIFERATION AND SPREADING OF EARLY TERM TROPHOBLASTS AND PLACENTAL VILLI. MODULATION OF COAGULATION AND ANGIOGENESIS FUNCTIONS
|
| Lanir N., Brenner B., Paz B., Gonen O., Snir A. |
| |
|
EFFECT OF FONDAPARINUX 2.5 MG ONCE DAILY ON ALL CAUSE MORTALITY: A META-ANALYSIS OF THROMBOPROPHYLAXIS TRIALS
|
| Turpie A.G., Eikelboom J. |
| |
|
EFFECT OF GLYCATED TAFI AND PLASMINOGEN ON FIBRINOLYSIS
|
| Verkleij C.J.N., Meijers J.C.M., Marx P.F. |
| |
|
EFFECT OF GLYCOPEGYLATION ON THE PHARMACOKINETIC PROPERTIES OF FVIIA
|
| Sorensen B.B., Karpf D., Groth A.V., Bysted B.V., Hermit M.B., Tranholm M., Bjørn S.E., Kinealy K., Zopf D., Bayer R.J., Kalo M.S., Stennicke H.R. |
| |
|
EFFECT OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS, PHARMACODYNAMICS AND TOLERABILITY OF RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR
|
| Halabi A., Kubitza D., Zuehlsdorf M., Becka M., Mueck W., Maatouk H. |
| |
|
EFFECT OF HIGH-DOSE APROTININ ON PLATELET FUNCTION AFTER NORMOTHERMIC CARDIOPULMONARY BYPASS IN CHILDREN CARDIAC SURGERY
|
| Flaujac C., Pouard P., Boutouyrie P., Emmerich J., Bachelot-Loza C., Lasne D. |
| |
|
EFFECT OF HOMOCYSTEINE ON CLOT STRUCTURE AND FIBRINOLYSIS
|
| Marchi R.C., Carvajal Z., Weisel J. |
| |
|
EFFECT OF HUMAN TERT TRANSFECTION ON GENE EXPRESSION PROFILING IN NORMAL HUMAN CORONARY ARTERY ENDOTHELIAL CELLS
|
| Matsubara Y., Murata M., Yabe M., Ikeda Y. |
| |
|
EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON ANGIOGENESIS
|
| Mousa S.A., Johansen K.B. |
| |
|
EFFECT OF LOW MOLECULAR WEIGHT HEPARIN ON HUMAN ENDOTHELIAL TISSUE FACTOR PATHWAY INHIBITOR RELEASE
|
| Mousa S.A., Johansen K.B. |
| |
|
EFFECT OF METHYLENE BLUE (MB) TREATMENT OF FRESH FROZEN PLASMA (FFP) ON CALIBRATED AUTOMATED THROMBOGRAPHY (CAT) AND ROTATIONAL THROMBOELASTOMETRY (ROTEM)
|
| Luddington R.J., Cardigan R.A. |
| |
|
EFFECT OF MICROSPHERE EMBOLI ON THE VENTILATION-PERFUSION RELATIONSHIP IN THE RABBIT - A PILOT STUDY
|
| Berthelsen L.O., Kristensen A.T., Hedenstierna G., Nyborg N.C.B., Tranholm M., Pedersen H.D. |
| |
|
EFFECT OF NATRIURETIC PEPTIDES ON ANGIOGENIC PROPERTIES OF HUMAN ENDOTHELIAL CELLS
|
| Jerczynska H., Cierniewski C.S., Pawlowska Z. |
| |
|
EFFECT OF NYTROXYL (HNO) AND NITRIC OXIDE (NO) ON PROTEIN KINASE ACTIVATION PATHWAY IN HUMAN PLATELET
|
| Bermejo E., Powazniak Y., Sáenz D., Alberto M.F., Bari S., Lazzari M.A., Rosenstein R. |
| |
|
EFFECT OF NYTROXYL AND NITRIC OXIDE ON HUMAN PLATELET ARACHIDONATE METABOLISM
|
| Bermejo E., Sáenz D., Chianelli M., Bari S., Lazzari M.A., Rosenstein R. |
| |
|
EFFECT OF ORAL CONTRACEPTIVES ON THROMBIN GENERATION MEASURED VIA CALIBRATED AUTOMATED THROMBOGRAPHY
|
| Tchaikovski S.N., van Vliet H.A.A.M., Thomassen M.L.G.D., Bertina R.M., Rosendaal F.R., Sandset P.M., Helmerhorst F.M., Tans G., Rosing J. |
| |
|
EFFECT OF PH AND TEMPERATURE ON ADAMTS-13 CATALYSIS
|
| De Cristofaro R., Di Stasio E., Scaldaferri F., Peyvandi F., Palla R., Mannucci P. |
| |
|
EFFECT OF PRASUGREL AND HIGH DOSE CLOPIDOGREL ON PLATELET FUNCTION AS ASSESSED BY POINT OF CARE AND OPTICAL AGGREGOMETRY
|
| Jakubowski J.A., Payne C.D., Li Y.G., Small D.S., Brandt J.T., Farid N.A., Salazar D.E., Winters K.J. |
| |
|
EFFECT OF PRE-ANALYTICAL VARIABLES ON MICROPARTICLE NUMBERS
|
| Lynch S.F., Stirling D., Ludlam C.A. |
| |
|
EFFECT OF PRESENCE OR ABSENCE OF RED CELLS ON EARLY GROWTH RATES OF PLATELET MURAL THROMBI
|
| Pivkin I.V., Richardson P.D., Karniadakis G.E. |
| |
|
EFFECT OF PROLAME, A 17 BETA-AMINOESTROGEN DERIVATIVE, ON CELL HEMOSTASIS
|
| Gonzalez-Zarate M., Fernandez-G J., del Valle-Mondragon L., Tenorio-Lopez F., Alvarado-Vazquez N., Rodriguez-Maldonado E., Zapata-Gomez E., de la Peña A. |
| |
|
EFFECT OF RECOMBINANT FACTOR VIIA VARIANT (NN1731) ON PLATELET FUNCTION, CLOT STRUCTURE AND FORCE ONSET TIME IN BLOOD FROM HEALTHY VOLUNTEERS AND HEMOPHILIA PATIENTS
|
| Brophy D.F., Martin E.J., Nolte M.E., Kuhn J.G., Carr M.E., Ezban M. |
| |
|
EFFECT OF RECOMBINANT FACTOR XIII-A ON ENDOTHELIAL BARRIER FUNCTION
|
| Gruda M., Turman S., Olsen E.H.N. |
| |
|
EFFECT OF REHABILITATION PROGRAM ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS AND INFLAMMATION IN PATIENTS UNDERGOING CARDIAC SURGERY
|
| Cesari F., Caporale R., Capalbo A., Marcucci R., Pucci N., Macchi C., Vannucci M., Caciolli S., Abbate R., Gensini G. |
| |
|
EFFECT OF RFVIIA (NOVOSEVEN,) AND FEIBA (FACTOR EIGHT INHIBITOR BYPASSING ACTIVITY) ON ANTICOAGULANT-INDUCED INHIBITION OF THROMBIN GENERATION IN PLATELET-RICH PLASMA (PRP)
|
| Pillitteri D., Scholz T., Wegert W., Kirchmaier C. |
| |
|
EFFECT OF RFVIIA AND NN1731 (RFVIIA ANALOGUE) ON THROMBOELASTOGRAPHY (TEG) IN WHOLE BLOOD OBTAINED FROM HAEMOPHILIA A DOGS
|
| Viuff D., Ezban M., Lind V., Dillow A., Raymer R., Merricks E., Nichols T. |
| |
|
EFFECT OF RFVIIA ON BLEEDING IN HES HEMODILUTED RABBITS
|
| Lauritzen B. |
| |
|
EFFECT OF SCLEROSANTS ON ANTITHROMBOTIC MECHANISMS, ENDOTHELIAL CELLS AND FIBRINOLYSIS
|
| Exner T., Parsi K., Herbert A., Ma D.D.F. |
| |
|
EFFECT OF SR-BI DEFICIENCY ON PLATELET AGGREGATION AND SUSCEPTIBILITY TO THROMBOSIS
|
| Korporaal S.J.A., Meurs I., Hauer A., Akkerman J.N., Kuiper J., van Berkel T.J.C., van Eck M. |
| |
|
EFFECT OF SURGICAL PROCEDURES AND SPECIFIED RISK FACTORS ON THE INCIDENCE OF PERI-OPERATIVE STROKE IN PATIENTS WITH ATRIAL FIBRILLATION (AF)
|
| White R.H., Kaatz S., Douketis J., Zhou H., Gage B.F. |
| |
|
EFFECT OF SYNTHETIC PEPTIDES DERIVED FROM STAPHYLOKINASE ON THE ACTIVATION OF PLASMINOGEN
|
| Okada K., Ueshima S., Matsuno H., Kawao N., Okamoto C., Tanaka M., Matsuo O. |
| |
|
EFFECT OF TETRAMETHYLPYRAZINE ON THE EXPRESSION OF TISSUE FACTOR INDUCED BY THROMBIN AND ITS MECHANISM
|
| He S., Sun Y., Wen Z., He X., Li B., Tang X. |
| |
|
EFFECT OF THE FIRST DOSE SIZE OF RECOMBINANT FACTOR VIIa ON TREATMENT EFFICACY OF FREQUENT JOINT BLEEDS IN PATIENT WITH HAEMOPHILIA A AND INHIBITOR
|
| Smejkal P., Muzik J., Bulikova A., Matyskova M., Dusek L., Penka M. |
| |
|
EFFECT OF THE IMPLEMENTATION OF A VENOUS THROMBOEMBOLISM PROPHYLAXIS GUIDELINE IN THE MANAGEMENT OF SURGICAL AND ORTHOPEDIC PATIENTS IN A PRIVATE TERTIARY HOSPITAL
|
| Maffei F.H.A., Sato A.C., Torggler Filho F., Atallah A. |
| |
|
EFFECT OF THE ORAL DIRECT THROMBIN INHIBITOR AZD0837 ON GLOMERULAR FILTRATION RATE IN ELDERLY HEALTHY SUBJECTS
|
| Schützer K.M., Svensson M., Dellstrand M., Björck K., Wåhlander K. |
| |
|
EFFECT OF TWO DOSES OF ORAL OESTROGEN REPLACEMENT THERAPY ON THE PROTEIN C SYSTEM IN POSTMENOPAUSAL WOMEN. A RANDOMISED DOUBLE BLIND PLACEBO-CONTROLLED STUDY
|
| Rousseau A., Robert A., Torchin D., Zannad F., Lacut K., Libersa C., Dasque E., Demolis J., Simon T. |
| |
|
EFFECT OF VARIATIONS OF SINGLE FACTOR ACTIVITY ON THROMBIN GENERATION AS DETERMINED BY THE THROMBIN DYNAMICS TEST
|
| Calatzis A., Spannagl M., Schramm W. |
| |
|
EFFECT OF VITAMIN K FOR WARFARIN REVERSAL ON ELEMENTS OF THE TISSUE FACTOR PATHWAY
|
| Needham J., Blann A., Milne A.E. |
| |
|
EFFECTIVE PATHOGEN REDUCTION FOR A PLASMA-DERIVED PROTHROMBIN COMPLEX CONCENTRATE THROUGH MULTIPLE DEDICATED MEASURES
|
| Nowak T., Schäfer W., Gröner A. |
| |
|
EFFECTIVE TREATMENT OF INTRACRANIAL HEMORRHAGE IN A SEVERE HEMOPHILIA B PATIENT
|
| Zanon E., Sartori M., Saggiorato G., Mardari R., Manara R., Cella G. |
| |
|
EFFECTIVENESS OF CHRONIC ANTIPLATELET TREATMENT BY ASPIRIN OR CLOPIDOGREL AS DETERMINED BY MULTIPLE ELECTRODE AGGREGOMETRY
|
| Calatzis A., Spannagl M. |
| |
|
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH ELEVATED INR VALUES: RESULTS OF RANDOMIZED TRIAL EXAMINING CLINICAL OUTCOMES
|
| Crowther M.A., Ageno W., Garcia D., Wang L., Witt D., Clark N., Blostein M., Kahn S., Schulman S., Kovacs M.J., Wells P., Anderson D., Kearon C., Ginsberg J., Selby R., Siragusa S., Silingardi M., Douketis J. |
| |
|
EFFECTIVENESS OF LOW DOSE ORAL VITAMIN K FOR PATIENTS WITH INR VALUES OF MORE THAN 10.0: RESULTS OF A PROSPECTIVE COHORT STUDY
|
| Crowther M.A., Garcia D., Ageno W., Wang L., Witt D., Clark N., Blostein M., Kahn S., Schulman S., Wells P., Anderson D., Kearon C., Ginsberg J., Selby R., Kovacs M.J., Siragusa S., Silingardi M., Douketis J. |
| |
|
EFFECTS AND MECHANISMS OF BUYANG HUANWU DECOCTION ON THE CELL VIABILITY AND TF EXPRESSION INDUCED BY ANG? IN ENDOTHELIAL CELLS
|
| Li J.L., Xiong S.L., Zhu W.H. |
| |
|
EFFECTS OF 7 KDA STREPTOKINASE FRAGMENT ON THE RABBIT HAEMOSTASIS SYSTEM
|
| Gavrylyuk S.P., Kucherenko M.E., Savchuk O.M. |
| |
|
EFFECTS OF 8-PRENYLNARINGENIN, A NOVEL PHYTOESTROGEN, ON HUMAN PLATELETS
|
| Zanfa M., Baldassarri S., Sarasso C., Appendino G., Bertoni A., Sinigaglia F. |
| |
|
EFFECTS OF A FLAVANOL-RICH COCOA BEVERAGE ON PLATELET AND LEUCOCYTE FUNCTION IN MAN
|
| May J.A., Fox S.C., Heptinstall S., Kwik-Uribe C. |
| |
|
EFFECTS OF A TOLL-LIKE RECEPTOR ANTAGONIST AND ANTI-ANNEXIN A2 ANTIBODIES ON BINDING AND ACTIVATION OF DECIDUAL CELLS BY ANTIBETA2GLYCOPROTEIN I ANTIBODIES
|
| Borghi M., Raschi E., Scurati S., Grossi C., Chen P., Pierangeli S.S., Meroni P. |
| |
|
EFFECTS OF AGE AND DIFFERENT CUT-OFF VALUES ON USE OF D-DIMER (DD) TESTING TO ESTABLISH DURATION OF ORAL ANTICOAGULATION TREATMENT (OAT) AFTER VENOUS THROMBOEMBOLISM (VTE)
|
| Legnani C., Cosmi B., Cini M., Mattarozzi S., Pengo V., Palareti G. |
| |
|
EFFECTS OF AN INHIBITOR OF NUCLEAR FACTOR-KAPPA B (NF-KB) ON THROMBOGENIC PROPERTIES OF ANTIPHOSPHOLIPID ANTIBODIES IN VIVO
|
| Montiel-Manzano G., Romay-Penabad Z., Papalardo E., Pierangeli S.S. |
| |
|
EFFECTS OF ANTI-BETA2-GLYCOPROTEIN I ANTIBODIES FROM APL PATIENTS WITH APS OR WITH LEPROSY IN AN IN VIVO MODEL OF APS
|
| Vega-Ostertag M.E., Forastiero R.R., Martinuzzo M., de Larrañaga G., Pierangeli S.S. |
| |
|
EFFECTS OF ARGATROBAN A THROMBIN INHIBITOR - ON THE FIBRIN GEL PERMEABILITY AND THE HEMOSTASIS BALANCE IN PLASMA
|
| He S., Blomback M. |
| |
|
EFFECTS OF CHEMOTHERAPY AGENTS ON ENDOTHELIAL AND MONOCYTE HEMOSTASIS
|
| Swystun L.L., Shin L.Y.Y., Beaudin S., Liaw P.C. |
| |
|
EFFECTS OF DIABETES ON THE PREVALENCE OF ASPIRIN RESISTANCE DURING LOW DOSE ASPIRIN THERAPY
|
| Tantry U.S., Bliden K.P., Chaganti S.K., DiChiara J., Gurbel P.A. |
| |
|
EFFECTS OF DU-176B, A NOVEL DIRECT FACTOR XA INHIBITOR, ON PROTHROMBINASE ACTIVITY AND PLATELET AGGREGATION IN VITRO
|
| Shibano T., Tsuji N., Kito F., Fukuda T., Furugohri T., Morishima Y. |
| |
|
EFFECTS OF E5555, A PROTEASE-ACTIVATED RECEPTOR-1 ANTAGONIST, ON THE INFLAMMATORY MARKERS IN VITRO
|
| Kogushi M., Yokohama H., Kitamura S., Hishinuma I. |
| |
|
EFFECTS OF FIBRINOGEN LEVELS AND CLOT STRENGTH IN THE PRESENCE OF THROMBOCYTOPENIA
|
| Lang T.H., Scheinichen D., Metzler H., Piepenbrock S., Bornscheuer A. |
| |
|
EFFECTS OF JNJ-28045446 ON P2Y12 ADP RECEPTOR FUNCTION IN VITRO AND IN VIVO
|
| Chen C., Haertlein B., Parry T.J., Zhang H., Ye H., Maryanoff B., Damiano B.P. |
| |
|
EFFECTS OF LOW DOSE ENDOTOXEMIA ON ENDOTHELIAL PROGENITOR CELLS IN HUMANS
|
| Mayr F.B., Spiel A.O., Leitner J.M., Firbas C., Sieghart W., Jilma B. |
| |
|
EFFECTS OF ORAL (OC) AND TRANSDERMAL (TC) HORMONAL CONTRACEPTION ON COAGULATION FACTORS AND ACTIVATED PROTEIN C RESISTANCE: IMPLICATIONS FOR THROMBOSIS RISK
|
| Cushman M., Johnson J.V., Lowell J., Rosing J., Badger G. |
| |
|
EFFECTS OF PARTICULATE MATTER AIR POLLUTION ON INFLAMMATION AND HAEMOSTASIS
|
| Rudez G., Gerlofs-Nijland M.E., van de Reijt F.H.J., Janssen N.A.H., Ameling C., Leebeek F.W.G., Cassee F.R., de Maat M.P.M. |
| |
|
EFFECTS OF PITAVASTATIN AND EICOSAPENTAENOIC ACID ON PLATELET-DERIVED MICROPARTICLES AND ADIPONECTIN IN HYPERLIPIDEMIC PATIENTS WITH TYPE 2 DIABETES MELLITUS
|
| Nomura S., Inami N., Shouzu A., Omoto S., Tanaka A., Nanba M., Shouda Y., Takahashi N., Kimura Y., Iwasaka T. |
| |
|
EFFECTS OF RECOMBINANT FACTOR VIIA (NOVOSEVEN) ON RESTORING THROMBIN GENERATION IN PATIENTS WITH HEMOPHILIA A AND ANTIBODIES TO FACTOR VIII
|
| Eichinger S., Lubsczyk B., Gleiss A., Quehenberger P., Kyrle P.A. |
| |
|
EFFECTS OF SHORT TERM STATIN PRE-TREATMENT AND SUBSEQUENT LOW DOSE ENDOTOXEMIA ON CIRCULATING ENDOTHELIAL PROGENITOR CELLS IN HEALTHY VOLUNTEERS
|
| Spiel A.O., Mayr F.B., Leitner J.M., Firbas C., Sieghart W., Jilma B. |
| |
|
EFFECTS OF THE FACTOR V G1691A MUTATION AND THE FACTOR II G20210A VARIANT ON THE CLINICAL EXPRESSION OF SEVERE HEMOPHILIA A ( 1%) IN CHILDREN
|
| Nowak-Gottl U., Kurnik K., Escuriola Ettingshausen C., Schobess R., Bogdanova N. |
| |
|
EFFECTS ON PLATELET AND LEUCOCYTE FUNCTION BY INTRAVENOUS CHINESE MEDICINE WIDELY USED FOR PATIENTS WITH ISCHAEMIC DISEASE IN CHINA
|
| Zhao L., Lin J.N., Gaudry L., Luo R.Z., Dunkley S. |
| |
|
EFFEKT OF PARAPROTEINS ON PLATELET AGGREGATION
|
| Djunic I.S., Elezovic I.V., Milosevic Jovcic N.M., j. Ilic V.L., Suvajdzic N.D., Bila J.S., Vidovic A.D., Tomin D.S. |
| |
|
EFFICACY AND SAFETY OF A HIGHLY PURIFIED FACTOR IX CONCENTRATE IN PAEDIATRIC PATIENTS WITH HAEMOPHILIA B - RESULTS OF A CLINICAL TRIAL AND A POST MARKETING SURVEILLANCE STUDY
|
| Klukowska A., Auerswald G., Vdovin V., Svirin P., Laguna P., Jansen M., Feddern J. |
| |
|
EFFICACY AND SAFETY OF A NOVEL HANSENULA POLYMORPHA -DERIVED RECOMBINANT RB-VARIANT HIRUDIN FOR THROMBOPROPHYLAXIS IN ORTHOPAEDIC PATIENTS
|
| Goubran H.A., Hanna A.A.Z., Sholkamy S. |
| |
|
EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX ADMINISTERED BY CONTINUOUS INFUSION IN HAEMOPHILIA B PATIENTS UNDERGOING SURGICAL PROCEDURES
|
| Négrier C., Chamouard V., Claeyssens S., Gautier P., Bertrand M., Fleury R., Beaufort C., Knuchel N., Bridey F. |
| |
|
EFFICACY AND SAFETY OF A SOLVENT-DETERGENT TREATED AND 15-NM FILTERED HUMAN COAGULATION FACTOR IX IN PREVIOUSLY UNTREATED PATIENTS (PUPS) WITH HAEMOPHILIA B
|
| Durin A., Bridey F., Goudemand J., Betafact Study Group |
| |
|
EFFICACY AND SAFETY OF FVIII WITH PEGYLATED LIPOSOMES IN HAEMOPHILIA A
|
| Spira J., Pluyshch O.P., Andreeva T.A., Khametova R.N. |
| |
|
EFFICACY AND SAFETY OF HIGH DOSES OF FEIBA FOR MAJOR SURGERY IN A PATIENT WITH HAEMOPHILIA A AND HIGH-TITRE INHIBITOR
|
| Longoni R., Vanelli R., Montani N., Bocchi L., Gamba G. |
| |
|
EFFICACY AND SAFETY OF HIGHLY PURIFIED VWF/FVIII CONCENTRATES IN THE TREATMENT OF INHERITED VON WILLEBRAND DISEASE: RESULTS FROM THE RETROSPECTIVE ITALIAN STUDY ON 103 CASES
|
| Federici A.B., Mazzucconi M.G., Barillari G., Musso R., Zanon E., Castaman G., Targhetta R., Mancuso G., Muleo G., Coppola A., D'Incà M., Gamba G., Latella M., Schinco P.C., Valdrè L., Mannucci P.M. |
| |
|
EFFICACY AND SAFETY OF RECOMBINANT ACTIVATED FACTOR VII (NOVOSEVEN) IN TRAUMA AND SURGERY PATIENTS WITH MASSIVE BLEEDING A REGISTER ANALYSIS
|
| Koscielny J., Kalus U., Kiesewetter H., Grounds M. |
| |
|
EFFICACY AND SAFETY OF WARFARIN MANAGEMENT IN US ANTICOAGULATION CLINICS
|
| Nutescu E.A., Vats V., Blackburn J.C., Ansell J., Wittkowsky A., Shapiro N., Schumock G.T. |
| |
|
EFFICACY OF A FVIII/VWF CONCENTRATE AS REPLACEMENT THERAPY IN PREVENTING EXCESSIVE BLEEDING IN SUBJECTS WITH CONGENITAL VON WILLEBRAND DISEASE (VWD) WHO UNDERWENT SURGICAL OR INVASIVE PROCEDURES
|
| Aledort L.M., Rivard G., Kessler C.M. |
| |
|
EFFICACY OF ANTI-COAGULATION AND ANTI-INFLAMATORY THERAPY FOR SEVERE SEPSIS
|
| Eguchi Y. |
| |
|
EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED PREVENTION
|
| Ewenstein B., Patrone L., Schroth P., Spotts G., Fritsch S., Pavlova B., Ehrlich H. |
| |
|
EFFICACY OF ANTIHEMOPHILIC FACTOR (RECOMBINANT), PLASMA/ALBUMIN-FREE METHOD (RAHF-PFM) IN BLEED TREATMENT
|
| Ewenstein B., Patrone L., Schroth P., Casey K., Fritsch S., Pavlova B., Ehrlich H. |
| |
|
EFFICACY OF ENOXAPARIN IN PREVENTING ADVERSE FETO-MATERNAL OUTCOMES IN CARRIERS OF ANTICOAGULANTS DEFICIENCY
|
| Grandone E., de Stefano V., Rossi E., Cappucci F., Za T., Colaizzo D., Tiscia G., Margaglione M. |
| |
|
EFFICACY OF FACTOR XIII SUBSTITUTION IN CHILDREN WITH INFLAMMATORY BOWEL DISEASE
|
| Dasi M.A., Villa P., Santos M.T., Ribes C., Monteagudo E., Carreras C. |
| |
|
EFFICACY OF FONDAPARINUX IN HEPARIN-INDUCED THROMBOCYTOPENIA WITH OR WITHOUT THROMBOEMBOLIC COMPLICATIONS
|
| Piovella F., Barone M., Piovella C., Beltrametti C., D'Armini A.M., De Amici M., Emmi V., Arici V., Carnevale L., Maurelli M., Barco S.L., Moratti R. |
| |
|
EFFICACY OF FONDAPARINUX IN MEDICAL PATIENTS WITH RESTRICTED MOBILITY ACCORDING TO THE ENDPOINT PROPOSED BY THE EUROPEAN COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)
|
| Cohen A.T., Turpie A.G., Eikelboom J. |
| |
|
EFFICACY OF OMEGA-3 FATTY ACIDS IN LOWERING LIPOPROTEIN(A) LEVELS
|
| Marcucci R., Sofi F., Cellai A., Fedi S., Falciani M., Rogolino A., Ciucciarelli L., Abbate R., Gensini G., Prisco D. |
| |
|
EFFICACY OF TEACHING CLINICAL CLERKS AND RESIDENTS ABOUT MANAGEMENT OF BLEEDING AND COAGULATION DISORDERS USING E-LEARNING
|
| Levinson A.J., Garside S., Chan A., Pai M., Webert K., Walker I.R. |
| |
|
EFFICACY OF WHOLE BLOOD PLATELET AGGREGATION IN THE EVALUATION OF BLEEDING OR THROMBOTIC TENDENCIES
|
| Spears M.D., Kim A.Y., Yassine J., Sarode R. |
| |
|
EFFICIENT INDUCTION OF IMMUNE TOLERANCE TO FIX FOLLOWING DIRECT INTRAMUSCULAR GENE TRANSFER
|
| Cohn E.F., Kelly M.E., Zhuo J., Chao H. |
| |
|
EFFICIENT PRION REMOVAL DURING THE MANUFACTURING PROCESS OF BETAFACT, A HIGH-PURITY PLASMA DERIVED FACTOR IX
|
| Arrabal S., Tellier M., Porte P., Kimmel-Jehan C., Chtourou S., Flan B. |
| |
|
EFFICIENT SECRETION OF BIOENGINEERED COAGULATION FACTOR VIII INTO THE MILK OF TRANSGENIC ANIMALS
|
| Pipe S.W., Miao H.Z., Butler S.T., Kaufman R.J., Calcaterra J., Velander W.H. |
| |
|
ELEVATED D-DIMER LEVELS IN PATIENTS WITH DEEP VEIN THROMBOSIS
|
| Matsumoto T., Wada H., Abe Y., Kobayashi T., Yamada N., Nobori T. |
| |
|
ELEVATED ENDOGENOUS THROMBIN POTENTIAL (ETP) IS ASSOCIATED WITH AN INCREASED RISK OF A FIRST DEEP VENOUS THROMBOSIS BUT NOT WITH RECURRENCE
|
| van Hylckama Vlieg A., Christiansen S.C., Luddington R., Cannegieter S.C., Rosendaal F.R., Baglin T.P. |
| |
|
ELEVATED FACTOR XIII LEVEL IS ASSOCIATED WITH AN INCREASED RISK OF MYOCARDIAL INFARCTION IN WOMEN
|
| Bereczky Z., Balogh E., Katona É., Kárpáti L., Czuriga I., Édes I., Muszbek L. |
| |
|
ELEVATED LEVELS OF CIRCULATING PROCOAGULANT MICROPARTICLES IN PATIENTS WITH BETA-THALASSEMIA INTERMEDIA
|
| Habib A., Kunzelmann C., Shamseddeen W., Taleb S., Isma'eel H., Zobairi F., Freyssinet J., Taher A. |
| |
|
ELEVATED LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH PREVIOUS MYOCARDIAL INFARCTION
|
| Silveira A., Scanavini D., Boquist S., Ericsson C., Morrissey J.H., Hamsten A. |
| |
|
ELEVATED MARKERS OF INFLAMMATION IN THE ACUTE PHASE OF DEEP-VEIN THROMBOSIS ARE A RISK FACTOR FOR ELEVATED VENOUS RESISTANCE AS A PROXY OF THE POST-THROMBOTIC SYNDROME
|
| Roumen-Klappe E.M., van Rossum J., Janssen M.C.H., Holewijn S., van Bokhoven M., Kaasjager K., Wollersheim H., den Heijer M. |
| |
|
ELEVATED PLASMA FREE FATTY ACID LEVEL (MYRISTIC ACID, PALMITIC ACID, STEARIC ACID) IN TYPE 2 DIABETIC INDIVIDUAL
|
| Ou Y.J., Hsieh M.C., Jang R.C., Wu H.L. |
| |
|
ELEVATED PLASMA GAS6 LEVELS ARE ASSOCIATED WITH CLOT BURDEN AND UNDERLYING MALIGNANCY IN DEEP-VEIN THROMBOSIS
|
| Rao D., Holcroft C., Kahn S.R., Blostein M. |
| |
|
ELEVATED PLASMA LEVELS OF FACTOR VIIA-ANTITHROMBIN COMPLEXES IN PATIENTS WITH ANTIPHOSPHOLIPID ANTIBODIES
|
| Roubey R.A.S., Lovell T., Morrissey J.H. |
| |
|
ELEVATED PLASMA LEVELS OF THROMBOSPONDIN-1 (TSP1) ARE ASSOCIATED WITH INCREASED LEVELS OF TGF-BETA AND PRO-INFLAMMATORY CYTOKINES IN RHEUMATOID ARTHRITIS PATIENTS
|
| Rico M.C., Manns J.M., Driban J.B., Nguyen H.H., Beharry N., Reddy M., Uknis A.B., DeLa Cadena R.A. |
| |
|
ELEVATED PLASMIN-ALPHA2-ANTIPLASMIN LEVELS IN SYSTEMIC AMYLOIDOSIS INDICATE ACTIVATION OF THE FIBRINOLYTIC SYSTEM
|
| Bouma B., Maas C., Hazenberg B.P.C., Lokhorst H., Gebbink M.F.B.G. |
| |
|
ELEVATED SERUM LEVELS OF LIGHT IN PULMONARY ARTERIAL HYPERTENSION-POTENTIAL INVOLVEMENT IN THROMBUS FORMATION
|
| Otterdal K., Andreassen A.K., Yndestad A., Sandberg W.J., Pedersen T.M., Ueland T., Brosstad F.R., Aukrust P., Damås J.K. |
| |
|
ELTROMBOPAG, AN ORAL, NON-PEPTIDE PLATELET GROWTH FACTOR, INCREASES PLATELET COUNTS AND DECREASES BLEEDING IN PATIENTS WITH IDIOPATHIC THROMBOCYTOPENIC PURPURA IN A PHASE III STUDY
|
| Bussel J., Shamsi T.S., Cheng G., Kovaleva L., Stone N., Mayer B., Poulin R., Arning M. |
| |
|
ELTROMBOPAG, THE ORAL PLATELET GROWTH FACTOR, INCREASED PLATELET COUNT AND DID NOT AFFECT PLATELET FUNCTION WHEN ADMINISTERED TO HEALTHY MALE SUBJECTS
|
| Jenkins J.M., Collins D.A., Williams D., Kitchen V.S. |
| |
|
EMODIN INHIBITS PDGF-BB-STIMULATED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION BY BLOCKING OF PDGF BETA-RECEPTOR PHOSPHORYLATION
|
| Jin Y., Lee J., Yu J., Im J., Park E., Seo J., Lim Y., Kim T., Yun Y. |
| |
|
EMOTIONAL IMPLICATIONS OF GENETIC TESTING AND ASPECTS OF COUNSELLING IN WOMEN PRIOR ORAL CONTRACEPTIVE INTAKE
|
| Gartner V., Eichinger S. |
| |
|
ENDOGENOUS PLATELET FACTOR 4 INCREASES ACTIVATED PROTEIN C GENERATION AND IMPROVES SURVIVAL AFTER LIPOPOLYSACCHARIDE CHALLENGE
|
| Kowalska M.A., Mahmud S.A., Lambert M.P., Poncz M., Slungaard A. |
| |
|
ENDOGENOUS PROTEIN C INHIBITS PULMONARY COAGULATION BUT FACILITATES BACTERIAL DISSEMINATION IN THE EARLY PHASE OF PNEUMOCOCCAL PNEUMONIA IN MICE
|
| Schouten M., van 't Veer C., Levi M.M., Esmon C.T., van der Poll T. |
| |
|
ENDOGENOUS THROMBIN POTENTIAL (ETP) IN PLASMA FROM PATIENTS WITH AMI DURING ANTITHROMBOTIC TREATMENT
|
| Brodin E., Seljeflot I., Arnesen H., Appelbom H., Hansen J.B. |
| |
|
ENDOGENOUS THROMBIN POTENTIAL IN 3183 PARTICIPANTS OF THE LUDWIGSHAFEN RISK AND CARDIOVASCULAR HEALTH (LURIC) STUDY
|
| Prüller F., Payer S., Ramschak H., Tiran B., Böhm B., März W. |
| |
|
ENDOGENOUS THROMBIN POTENTIAL IN PATIENTS WITH IDIOPATHIC VENOUS THROMBOSIS
|
| Lo Coco L., Malato A., Deidda I., Cigna V., Saccullo G., Anastasio R., Abbene I., Curiale S., Abbadessa V., Siragusa S. |
| |
|
ENDOGENOUS THROMBIN POTENTIAL IN PREGNANT WOMEN RECEIVING LOW MOLECULAR WEIGHT HEPARIN (LMWH)
|
| Hron G., Kollars M., Philipp K., Kyrle P.A., Eichinger S. |
| |
|
ENDOGENOUS THROMBIN POTENTIAL, TISSUE FACTOR ANTIGEN LEVELS AND FIBRINOLYSIS IN SICKLE CELL PATIENTS WITH AND WITHOUT PULMONARY HYPERTENSION
|
| van Oerle R., van Beers E.J., Schnog J.B., Brandjes D.P.M., Duits A.J., van Esser J., Spronk H.M.H., Hamulyak K., Biemond B.J., ten Cate H. |
| |
|
ENDOGENOUS THROMBIN POTENTIAL: FUNCTIONAL ROLE OF ALPHA-2-MACROGLOBULIN
|
| Ignjatovic V., Greenway A., Summerhayes R., Monagle P. |
| |
|
ENDOTHELIAL CELL TYPE AND ACTIVATION STATE AFFECTS SOLUBLE P-SELECTIN MEDIATED LEUKOCYTE ADHESION
|
| Woollard K.J., Dart A., Jackson S., Chin-Dusting J. |
| |
|
ENDOTHELIAL DYSFUNCTION CORRELATES WITH PLASMA FIBRINOGEN AND HDL CHOLESTEROL IN TYPE 2 DIABETIC PATIENTS WITH CORONARY ARTERY DISEASE
|
| Bosevski M., Borozanov V., Vavlukis M., Peovska I., Georgievska-Ismail L. |
| |
|
ENDOTHELIAL DYSFUNCTION IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION
|
| Carbo C., Diaz-Ricart M., Fernandez F., Rovira M., Mazzara R., Escolar G., Carreras E. |
| |
|
ENDOTHELIAL DYSFUNCTION IN HEMOPHILIA PATIENTS
|
| Sartori M.T., Bilora F., Zanon E., Varvarikis C., Saggiorato G., Campagnolo E., Cella G. |
| |
|
ENDOTHELIAL FUNCTION IN PATIENTS WITH ANTIPHOSPHOLIPID SYNDROME AND HISTORY OF VENOUS THROMBOSIS
|
| Stalc M., Poredos P., Peternel P., Tomsic M., Kveder T. |
| |
|
ENDOTHELIAL IMPACT OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
|
| Petropoulou A.D., Elalamy I., Gerotziafas G.T., Rendu F., Samama M.M., Marie J.P., Rio B. |
| |
|
ENDOTHELIAL MARKERS OF INJURY/REPAIR EQUILIBRIUM IN PATIENTS UNDERGOING CORONARY ANGIOPLASTY
|
| Sabatier F., Basire A., Bonello L., Paganelli F., Dignat-George F. |
| |
|
ENDOTHELIAL PROGENITOR CELLS
|
| Pearson J. |
| |
|
ENDOTHELIAL PROGENITORS AND CIRCULATING ENDOTHELIAL CELLS: REGENERATION VERSUS DEGENERATION
|
| Dignat-George F. |
| |
|
ENDOTHELIAL PROTEIN C RECEPTOR
|
| Esmon C.T. |
| |
|
ENDOTHELIAL PROTEIN C RECEPTOR A1 AND A3 HAPLOTYPES AND THE RISK OF VENOUS THROMBOEMBOLISM IN CARRIERS OF THE PROTHROMBIN G20210A MUTATION
|
| Navarro S., Medina P., Estellés A., Vayá A., Cubillo P., Mira Y., Villa P., Ferrando F., Bertina R.M., España F. |
| |
|
ENDOTHELIAL PROTEIN C RECEPTOR EXPRESSION IN BREAST CANCER
|
| Faioni E.M., Ferrero S., Esmon C.T., Falleni M., Tagliavacca L., Lussana F., Bosari S., Cattaneo M. |
| |
|
ENGINEERING A CHIMERIC SERINE PROTEASE INHIBITOR AS A PREVENTATIVE THERAPEUTIC FOR CARDIOVASCULAR DISEASE
|
| Rau J.C., Chang J.Y., Church F.C. |
| |
|
ENHANCED HEPARIN BINDING AFFINITIES INCREASE THE EFFICIENCIES AT WHICH THE BETA-ANTITHROMBIN III ISOFORM AND A RECOMBINANT ATIII VARIANT LOAD ONTO PENTASACCHARIDE-BEARING SURFACES UNDER FLOW
|
| Leng B., Lu A., Riesenfeld J., Shiu Y., Bock S.C. |
| |
|
ENHANCED PHARMACOKINETICS OF FACTOR IX AS A MONOMERIC FC FUSION
|
| Peters R.T., Bitonti A.J. |
| |
|
ENHANCED THROMBUS FORMATION AFTER CHRONIC CHLAMYDIA PNEUMONIAE INFECTION IN A MURINE CAROTID ARTERY THROMBOSIS MODEL
|
| de Kruif M.D., Hansen H., Keller T.T., van der Vorst L.P., van der Wal A.C., Spek A., Reitsma P.H., ten Cate H. |
| |
|
ENHANCED TOLEROGENIC PRESENTATION OF FVIII BY ANDROGRAPHOLIDE-TREATED IMMATURE DENDRITIC CELLS
|
| Qadura M., Othman M., Labelle A., Burnett E., Walker K., Hough C., Lillicrap D. |
| |
|
ENHANCED VIABILITY AND EX VIVO EXPANSION AND MATURATION OF CORD BLOOD MEGAKARYOCYTE PROGENITORS (MK-P) WITH FIBRONECTIN
|
| Deutsch V.R., Hubel E., Kay S., Katz B., Naparstek E., Grisaru D. |
| |
|
ENHANCEMENT OF SINGLE-CHAIN UROKINASE ACTIVITY BY PLATELET PROTEINS
|
| Baeten K.M., Booth N.A. |
| |
|
ENOXAPARIN 40 MG VERSUS NADROPARIN 0.3 ML IN THE PREVENTION OF VENOUS THROMBOEMBOLISM (VTE) IN COLORECTAL CANCER SURGERY ACCORDING TO AGE AND CREATININE CLEARANCE (CRCL)
|
| Simonneau G., Mismetti P. |
| |
|
ENOXAPARIN VERSUS HEPARIN PROPHYLAXIS FOR VENOUS THROMBOEMBOLISM AFTER ABDOMINAL ONCOLOGIC SURGERY: A RANDOMIZED DOUBLE-BLIND CONTROLLED TRIAL
|
| Petrov M., Anosov A., Piskunova N. |
| |
|
ENOXAPARIN VERSUS UNFRACTIONATED HEPARIN FOR VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTE ISCHEMIC STROKE PATIENTS
|
| Pineo G.F., Albers G.W., Bladin C., Fieschi C., Gabbai A.A., Kase C.S., O'Riordan W., Sherman D.G. |
| |
|
ENZYME KINETIC CHARACTERISATION OF THE ACTIVE FORM OF THE NOVEL ORAL DIRECT THROMBIN INHIBITOR AZD0837
|
| Gyzander E., Deinum J. |
| |
|
EP3 RECEPTORS - A NEW TARGET FOR INHIBITION OF PLATELET AGGREGATION AND PLATELET-LEUCOCYTE CONJUGATE FORMATION
|
| Heptinstall S., Anders R., Gurney M., Hermann D., Hartman D. |
| |
|
EPIDEMIOLOGIC, LABORATORY EVALUATION AND CLINICAL CHARACTERISTICS IN PATIENTS WITH THROMBOSIS
|
| Faranoush M., Vossough P., Ala F., Rastegarlari G., Sadeghi H., Namakian F., Malek M., Babaei M., Golpayegani M., Jazebi M., Shahshahani T., Hejazi S., Hedayatiasl A., Alavitoosi J. |
| |
|
EPIDEMIOLOGICAL STUDY OF VENOUS THROMBOEMBOLISM IN A BIG DANISH COHORT
|
| Severinsen M.T., Kristensen S.R., Overvad K., Dethlefsen C., Johnsen S.P. |
| |
|
EPIDEMIOLOGICAL STUDY: CAUSES OF DETHS IN PTOLEMAIDA CITY
|
| Makris M.P., Papamichos S.I., Makris L.P., Makris P.E. |
| |
|
EPIDEMIOLOGY AND ONE-YEAR OUTCOMES IN PATIENTS WITH ACQUIRED HEMOPHILIA A (AH) IN FRANCE: THE SACHA PROSPECTIVE STUDY
|
| Borg J., Levesque H. |
| |
|
EPIDEMIOLOGY OF BERNARD SOULIER DISEASE
|
| Faranoush M., Ala F., Vossough P., Rastegarlari G., Jazebi M., Shahshaahani T., Hejazi S., Alavitoosi J., Hedayatiasl A. |
| |
|
EPIDEMIOLOGY OF THROMBOEMBOLISM (TE) IN CHILDREN WITH CANCER
|
| Athale U., Lathia A., Cox S., Khan A., Pai N., Armstrong A., Odame I., Chan A.K.C. |
| |
|
EPINEPHRINE INDUCES LOCAL T-PA RELEASE VIA A NITRIC OXIDE-DEPENDENT PATHWAY IN HUMAN FOREARM
|
| Giannarelli C., Virdis A., De Negri F., Ghiadoni L., Magagna A., Salvetti A., Taddei S. |
| |
|
EPINEPHRINE REDUCES THE EFFECT OF ANTIPLATELET THERAPIES IN PATIENTS WITH ACUTE CORONARY SYNDROME (ACS). ROLE OF PI3K
|
| Moscardo A., Valles J., Fuset M., Ruano M., Santos T. |
| |
|
EPITOPE MAPPING OF COLLAGEN BINDING SITE IN HUMAN GLYCOPROTEIN VI (GPVI)
|
| Niimi M., Tao L., Kambayashi J., Sun B. |
| |
|
EPOTHILONE B INHIBITS NEOINTIMAL FORMATION AFTER RAT CAROTID INJURY THROUGH THE REGULATION OF CELL CYCLE-RELATED PROTEINS
|
| Lim Y., Kim T., Jin Y., Kim D., Kwon J., Son J., Jung J., Avery M., Hong J., Yun Y. |
| |
|
E-SELECTIN AND TFPI ARE ASSOCIATED WITH CAROTID INTIMA-MEDIA THICKNESS IN STABLE CORONARY PATIENTS: THE BASELINE FINDINGS OF THE MIAMI STUDY
|
| Porta B., Baldassarre D., Camera M., Amato M., Arquati M., Tremoli E., Cortellaro M. |
| |
|
ESTABLISHING REFERENCE VALUES FOR COAGULATION PARAMETERS IN PREGNANT WOMEN
|
| Temal C., Cirkel U., Eller T. |
| |
|
ESTABLISHMENT OF A FLOW CYTOMETRIC ASSAY FOR QUANTITATIVE DETECTION OF HUMAN PLATLET GLYCOPROTEIN VI BY A MOUSE POLYCLONAL ANTIBODY
|
| Wu S., Qu C., Wang J. |
| |
|
ESTABLISHMENT OF REFERENCE INTERVALS OF PLATELET FUNCTION ANALYZER-100 CLOSURE TIMES IN HEALTHY KOREAN ADULTS
|
| Chung H., Cho Y., Chi H., Jang S., Park C. |
| |
|
ESTIMATING THE INFLUENCE OF MEASUREMENT VARIABILITY ON DIAGNOSTIC ERRORS: A BAYESIAN MODEL APPLIED TO QUANTITATIVE D DIMER ASSAYS FOR THE EXCLUSION OF VENOUS THROMBOSIS
|
| Guerrero F., Concordet D., Freyburger G., Sie P. |
| |
|
ESTROGEN TREATMENT OF CONSTITUTIONAL TALL STATURE IN GIRLS: RISK OF THROMBOSIS OR BLEEDING?
|
| Rask O., Nilsson K., Berntorp E. |
| |
|
ESTROGEN USE, VARIANTS IN 24 CLOTTING GENES AND THE RISK OF THROMBOSIS IN POSTMENOPAUSAL WOMEN
|
| Smith N.L., Bis J.C., Hindorff L.A., Rice K., Lumley T., Kooperberg C., Wiggins K.L., Heckbert S.R., Rosendaal F.R., Psaty B.M. |
| |
|
ETHNIC DIFFERENCES IN A HUMAN MODEL OF TISSUE FACTOR- TRIGGERED COAGULATION
|
| Mayr F.B., Spiel A.O., Leitner J.M., Jilma B. |
| |
|
ETIOLOGY, CLINICAL COURSE AND TREATMENT OUTCOME OF PATIENTS WITH INFERIOR VENA CAVA THROMBOSIS
|
| Linnemann B., Schmidt H., Schindewolf M., Zgouras D., Erbe M., Grossmann R., Lindhoff-Last E. |
| |
|
EVALUATION BY SURFACE PLASMON RESONANCE OF VWF EFFECT ON MONOCLONAL ANTIBODY DIRECTED TO FVIII LIGHT CHAIN REACTIVITY
|
| Grancha S., Jorquera J.I. |
| |
|
EVALUATION FOR HYPERCOAGULOPATHY IN THALASSEMIA MAJOR PATIENTS IN ISFAHAN
|
| Moafi A., Sabri M., Abedini M. |
| |
|
EVALUATION OF 50 POTENTIAL MARKERS OF PULMONARY EMBOLISM FOR USE IN THE EMERGENCY DEPARTMENT
|
| Nordenholz K.E., Mitchell A.M., Kline J.A. |
| |
|
EVALUATION OF A NEW D-DIMER METHOD
|
| Alatri A., Paoletti O., Morstabilini G., Spotti E., Testa S. |
| |
|
EVALUATION OF A NEW FUNCTIONAL CLOTTING ASSAY FOR THE MONITORING OF HEPARIN AND HEPARINOID ANTICOAGULANTS BASED ON THROMBIN AND/OR FACTOR XA INHIBITION WITH CLINICAL PATIENT PLASMAS AT THREE UNIVERSITY MEDICAL CENTERS
|
| Schöni R., Walenga J., Samama M., Harenberg J., Drenth A.F., le Courvoisier-Flaujac C., Giese C., Rudin K., Bühler B., Wilmer M. |
| |
|
EVALUATION OF A NEW INR PORTABLE MONITOR
|
| Paoletti O., Alatri A., Morstabilini G., Mazzolari M., Testa S. |
| |
|
EVALUATION OF A NEW LATEX-BASED HOMOCYSTEINE ASSAY
|
| Cooper P.C., Hickey K.P., Cooper S.M., Kitchen S., Makris M. |
| |
|
EVALUATION OF A NEW, AUTOMATED QUANTITATIVE FACTOR XIII ASSAY
|
| Alhomsi K., Salem R.O., Morin K.A., Van Cott E.M. |
| |
|
EVALUATION OF A PRE-TEST CLINICAL SCORE FOR THE DIAGNOSIS OF HIT
|
| McRae S.J., Al Muslahi M., Duncan E.M., Tadros R., Lloyd J.V., Warkentin T.E. |
| |
|
EVALUATION OF A PROTOTYPE MULTIPLEX METHOD FOR EVALUATING PHOSPHOLIPID ANTIBODIES
|
| Gosselin R.C., Janatpour K.A., Owings J.T. |
| |
|
EVALUATION OF A RAPID PARTICLE GEL IMMUNO ASSAY (PAGIA) FOR DETECTION OF HEPARIN/PF4 ANTIBODIES (HPA)
|
| Castellone D.D., Peerschke E.E.I.B. |
| |
|
EVALUATION OF ALLOSTERIC INHIBITORS OF PAR1 ON PLATELET ACTIVATION
|
| Jeske W.P., Tydell J., Gilchrist A., Walenga J.M., Bakhos M. |
| |
|
EVALUATION OF CLOT DENSITY AS AN INTEGRAL MARKER OF COAGULOPATHY
|
| Zabolotskikh I.B., Sinkov S.V., Shaposhnikov S.A. |
| |
|
EVALUATION OF COAGULATION KINETICS USING THROMBELASTOGRAPHY
|
| Sørensen B., Christiansen K., Norengaard L., Larsen O., Fenger Eriksen C., Ingerslev J. |
| |
|
EVALUATION OF EFFICACY OF RADIOACTIVE SYNOVECTOMY IN RECURRENT JOINT BLEEDING IN HAEMOPHILIA
|
| Klukowska A., Czyrny Z., Krolicki L., Laguna P., Brzewski M. |
| |
|
EVALUATION OF IN-VITRO STABILITY AND MICROBIOLOGICAL SAFETY OF RECONSTITUTED VON WILLEBRAND FACTOR CONCENTRATE
|
| Peyrezabes E., Chamouard V., Bridey F., Gaillandre A., Samor B., Fleury R., Négrier C., Rugeri L. |
| |
|
EVALUATION OF LASER-INDUCED THROMBOLYSIS IN THE RAT THROMBOSIS MODELS: A PULSED GREEN LASER TECHNIQUE
|
| Matsumoto Y., Yamashita D., Yamashita Y., Okada H., Maeda Y., Shimizu Y., Nakayama T., Umemura K. |
| |
|
EVALUATION OF LIPOPROTEIN (A) IN ARGENTINIAN WOMEN WITH ADVERSED PREGNANCY OUTCOME
|
| Vega-Ostertag M.E., Marquez J.M., Forastiero R.R., Pagani F. |
| |
|
EVALUATION OF MILD HHCY IN THE DEVELOPMENT OF ATHEROSCLEROSIS IN APOE-DEFICIENT AND NORMAL MICE
|
| Aléssio A.C.M., Höehr N.F., Haddad R., Oliveira L.C., Annichino-Bizzacchi J.M. |
| |
|
EVALUATION OF ORTHOSTATIC BALANCE AT GROUND AND SLOPE LEVELS IN ADULT PATIENTS WITH HAEMOPHILIA
|
| Chang S.T., Chang C.C., Huang G.S., Ma H.I., Pan R.Y., Cheng S.N., Chen Y.C., Wang N.C., Chao T.Y., Lee S.P. |
| |
|
EVALUATION OF OUR CASES WITH GLANZMANN THROMBASTHENIA
|
| Salcioglu Z., Aydogan G., Akici F., Baslar Z., Sayilan Sen H.H.S., Aktay Ayaz N., Aldemir H., Yanilmaz O. |
| |
|
EVALUATION OF PEG-FVIII MOLECULES WITH PROLONGED HALF-LIVES IN A MURINE FVIII-DEPENDENT BLEEDING MODEL
|
| Liu T., Landskroner K.A., Cui Z., Canivel D., Newgren J., Tjandra H., Strauss J., Pierce G.F., Jesmok G.J., Jiang H. |
| |
|
EVALUATION OF PRO-TIME MICROCOAGULLATION SUSTEM
|
| Makris P.E., Papamichos S.I., Makris M.P. |
| |
|
EVALUATION OF THE ACCURACY OF A 99MTC-LABELLED MONOCLONAL ANTIBODY SPECIFIC FOR D-DIMER IN PATIENTS WITH SUSPECTED DEEP VEIN THROMBOSIS (DVT)
|
| Douketis J., Julian J., Ginsberg J., Haley S., Gu C., Eisenberg P., Gerometta M., Smart R., Levine M. |
| |
|
EVALUATION OF THE ACTIVITY OF BONE-SPECIFIC ALKALINE PHOSPHATASE AND TARTRATE-RESISTANT ACID PHOSPHATSE ISOFORM 5B IN HEMOPHILIC PATIENTS
|
| Cheng S.N., Chen Y.C., Huang K.S., Chao T.Y., Chiang J.L., Huang S.M. |
| |
|
EVALUATION OF THE ANTICOAGULANTS EDTA CONTAINING DISODIUM DIAZOLIDYL UREA TO PREVENT UNSOLICITED PLATELET ACTIVATION
|
| Ahnadi C.E., Pomerleau J., Chapman-Montgomery S., Grant A. |
| |
|
EVALUATION OF THE BEHAVIOR OF (QUATERNIZED) POLY[(2-DIMETHYLAMINO)ETHYL METHACRYLATE] AND (CROSSLINKED) N-CARBOXYETHYLCHITOSAN AND THEIR COMPLEXES IN CONTACT WITH BLOOD
|
| Danchev D., Yancheva E., Paneva D., Manolova N., Rashkov I., Mespouille L., Dubois P. |
| |
|
EVALUATION OF THE COAGUCHEK XS PLUS SYSTEM IN A SWISS COMMUNITY SETTING
|
| Deom A., Reber G., Tsakiris D., Hannes F., Plesch W.J. |
| |
|
EVALUATION OF THE EFFECT OF TWO DIFFERENT DOSES OF ASPIRIN IN PATIENTS UNDERGOING CABG
|
| Brambilla M., Centenaro C., Parolari A., Tremoli E., Camera M. |
| |
|
EVALUATION OF THE EFFECTS OF A SINGLE INFUSION OF FACTOR VIII ON WHOLE BLOOD COAGULATION THROMBOELASTOGRAPHY IN PATIENTS WITH SEVERE HAEMOPHILIA
|
| Lambert C., Dessomme B., Deneys V., Hermans C. |
| |
|
EVALUATION OF THE EFFICACY OF DUAL ANTITHROMBOTIC THERAPY WITH TWO MARKERS OF PLATELET ACTIVATION
|
| Mendolicchio L., Godino C., Figini F., Colombo A., Cianflone D., Maseri A., Ruggeri Z.M. |
| |
|
EVALUATION OF THE FACTOR XA (FXA) INHIBITOR, PRT054021 (PRT021), AGAINST ENOXAPARIN IN A RANDOMIZED TRIAL FOR THE PREVENTION OF VENOUS THROMBOEMBOLIC EVENTS AFTER TOTAL KNEE REPLACEMENT (EXPERT)
|
| Turpie A.G., Gent M., Bauer K., Davidson B.L., Fisher W., Huo M., Borow K., Frame V.B., Michalsky C., Gretler D.D., Romanko K., Sinha U. |
| |
|
EVALUATION OF THE HYPERLIPIDEMIA AND HYPERGLYCEMIA IN PROGESTERONE ONLY PILL USERS
|
| Kashanian M., Fekrat M. |
| |
|
EVALUATION OF THE NEW KIT HEMOSIL D-DIMER HS ON SEVERAL INSTRUMENTS COMPARED TO OTHER TURBIDIMETRIC AND ELISA METHODS
|
| Morelli B., Rampinini F., Garghetti E., Duca M., Cozzi M., Stefanin C. |
| |
|
EVALUATION OF THE POINT OF CARE MICRO-COAGULATION TESTS IN PEDIATRICS
|
| El Rouby S., Thompson J., Williams J., Jobes D. |
| |
|
EVALUATION OF THE RELATIONSHIP BETWEEN GESTATIONAL DIABETES MELLITUS AND A HISTORY OF POLYCYSTIC OVARIAN SYNDROME
|
| Kashanian M., Fazi Z., Pirak A. |
| |
|
EVALUATION OF THE SAFETY AND PHARMACOKINETICS OF A RAPID-ACTING RECOMBINANT FVII ANALOGUE, NN1731, IN HEALTHY MALE SUBJECTS
|
| Møss J., Scharling B., Ezban M., Møller Sørensen T. |
| |
|
EVALUATION OF THE THROMBOELASTOMETRY
|
| Viscardi Y., Chantarangkul V., Tripodi A. |
| |
|
EVALUATION OF THE USE OF RECOMBINANT FVIIA, NOVOSEVEN IN 28 GLANZMANN'S THROMBASTHENIA PATIENTS
|
| Lak M., Sharifian R.A., Toogeh G.R., Karimi K., Managhchi M.R., Behbehani R. |
| |
|
EVALUATION OF THROMBIN GENERATION CAPACITY IN PLASMA FROM PATIENTS WITH HIGH LEVELS OF FVIII, FIX OR FXI AND ONE SPONTANEOUS VENOUS THROMBOEMBOLIC EVENT
|
| Duboscq C., Ceresetto J., Shanley C., Stemmelin G., Doti C., Vicente M., Castedo G., Melgar M., Bullorsky E. |
| |
|
EVALUATION OF THROMBOELASTOGRAPHY (TEG) ASSAYS FOR MONITORING EX VIVO EFFECT OF RFVIIA (NOVOSEVEN) IN HAEMOPHILIA A AND B PATIENTS
|
| Viuff D., Permin L., Lind V., B Sørensen B., Andersen S., Buöen Stenmo C., Andersen E., I Johansson P., Lethagen S. |
| |
|
EVALUATION OF THROMBOLYTIC THERAPY WITH TISSUE-TYPE PLASMINOGEN ACTIVATOR (T-PA) FOR PROSTHETIC VALVE THROMBOSIS IN CHILDREN: A SINGLE INSTITUTION EXPERIENCE
|
| Damme A.V., Williams S., Caldarone C.A., Chan A.K., Brandao L.R. |
| |
|
EVALUATION OF THROMBOPHILIA SCREENING IN WOMEN WITH OBSTETRICAL COMPLICATIONS: A "REAL WORLD" EXPERIENCE
|
| Henrard S., Maréchal C., Lambert C., Deneys V., Hermans C. |
| |
|
EVALUATION OF TWO SOLUBLE FIBRIN MONOMER ASSAYS
|
| Haas F.J.L.M., Hackeng C.M., Schutgens R.E.G., Biesma D.H. |
| |
|
EVALUATION OF VARYING CALCIUM CONCENTRATIONS TO IDENTIFY ANTIB2-GLYCOPROTEIN I LUPUS ANTICOAGULANTS WITH A SILICA CLOTTING TIME METHOD FOR LUPUS ANTICOAGULANT TESTING
|
| Cueto C., Bottenus R., Triscott M. |
| |
|
EVALUATION OF VENOUS THROMBOEMBOLIC RISK PROFILES IN ACUTELY ILL MEDICAL PATIENTS IN HOSPITAL AND OUTPATIENT SETTINGS: THE STATUS REGISTRY
|
| Haas S.K., Kroeger K., Regitz-Zagrosek V., Schellong S.M., Zotz R.B., Kienitz C., Paar D. |
| |
|
EVALUATION OF VON WILLEBRAND FACTOR IN A MURINE MODEL UNDER STEROID HORMONE TREATMENT
|
| Sánchez-Luceros A., Kempfer A.C., Farías C.E., Piazzón I., Nepomnaschy I., Lazzari M.A. |
| |
|
EVALUATION OF VWF CONCENTRATE ACTIVITY ASSAYS EMPLOYING COLLAGEN TYPES I AND III
|
| Stadler M., Gruber G., Janisch S., Kaiser R., Zapfl C., Brainovic J., Cortes R., Gruber R., Roemisch J., Svae T. |
| |
|
EVIDENCE FOR A HIGH AFFINITY ADAMTS13 BINDING SITE DISTAL TO THE VWF A DOMAINS
|
| Zanardelli S., Chion C.K.N.K., Lenting P.J., De Groot E., Lane D.A. |
| |
|
EVIDENCE FOR AN ALTERNATIVE REGULATION OF THE ACTIVITY OF THE BETA3-INTEGRIN ALPHAVBETA3 IN THE ABSENCE OF THE HIGHLY CONSERVED ALPHA-SUBUNIT GFFKR MOTIF
|
| Ahrens I., Heeskens J., Bassler N., Neudorfer I., Bode C., Peter K. |
| |
|
EVIDENCE FOR THROMBIN-INDUCED PLATELET ACTIVATION INDEPENDENT OF PAR1, PAR4, AND GPIB-IX-V
|
| Lova P., Campus F., Mancini F., Balduini C., Torti M. |
| |
|
EVIDENCE FOR TWO FUNCTIONAL CALCIUM-BINDING SITES ON ADAMTS13
|
| Gardner M.D., Crawley J.T.B., Lane D.A., Chion C.K.N.K. |
| |
|
EVIDENCE OF ASPIRIN EXCRETION FROM PLATELET BY MRP4 TRANSPORT RESPONSIBLE FOR REDUCED DRUG ACTIVITY IN PATIENTS AT 5 DAYS CABS
|
| Mattiello T., Guerriero R., Lotti L., Gaudio C., Frati L., Pucinelli F.M. |
| |
|
EVIDENCE OF PROTEIN C (PC) GLA DOMAIN AMINO ACIDS CRUCIAL FOR INTERACTION WITH PROTEIN S (PS)
|
| Saller F., Gandrille S., Villoutreix B., Kaabache T., Aiach M., Emmerich J., Borgel D. |
| |
|
EVOLUTION OF D-DIMERS LEVELS DURING HEPARIN THERAPY OF PATIENTS WITH CEREBRAL VENOUS THROMBOSIS
|
| Tardy B., Tardy-Poncet B., Venet C., Guyomarc'h S., Garnier P., Laporte S., Campos L., Zeni F. |
| |
|
EVOLUTIONARY CONSERVED B-DOMAIN SEQUENCES CONTRIBUTE TO MAINTAINING FACTOR V AS A PROCOFACTOR
|
| Bos M.H.A., Boltz M., Camire R.M. |
| |
|
EX VIVO ANTITHROMBOTIC EFFECTS OF ANTI GPVI FAB FRAGMENT IN NON-HUMAN PRIMATES WITHOUT MODIFICATION OF GPVI EXPRESSION
|
| Jandrot-Perrus M., Ohlmann P., Hechler B., Loyau S., Ravanat C., Dumont B., Wanert F., Herrenschmidt N., Gachet C. |
| |
|
EX VIVO PRIMING OF EPC WITH SDF-1 BEFORE TRANSPLANTATION COULD INCREASE THEIR PROANGIOGENIC POTENTIAL
|
| Zemani F., Fauvel-Lafeve F., Bruel A., Bieche I., Laurendeau I., Galy-Fauroux I., Fischer A., Boisson-Vidal C. |
| |
|
EXCESS BODY FAT AND THE RISK OF RECURRENT VENOUS THROMBOEMBOLISM
|
| Eichinger S., Hron G., Hirschl M., Bialonczyk C., Kyrle P.A. |
| |
|
EXCESS THROMBIN GENERATION IN PATIENTS AFTER ON-PUMP CARDIAC SURGERY
|
| König V., Reinhöfer M., Oberle V., Gummert J., Barz D., Marx G., Lösche W. |
| |
|
EXERCISE IMPROVES THE GLOBAL HEMOSTATIC EFFICACY IN SEVERE HEMOPHILIA A DOGS, AS DETERMINED BY THROMBELASTOGRAPHY
|
| Othman M., Webster S., Chirinian Y., Lillicrap D. |
| |
|
EXOSITES IN THE SUBSTRATE SPECIFICITY OF BLOOD COAGULATION REACTIONS
|
| Bock P.E., Panizzi P., Verhamme I.M.A. |
| |
|
EXPERIENCES IN THERAPY AND OUTCOME OF ADOLESCENTS WITH ACUTE VENOUS THROMBOSIS
|
| Heller C., Klingebiel T., Kreuz W. |
| |
|
EXPERIMENTAL MODEL OF THROMBOSIS IN RABBIT'S MARGINAL EAR VEIN
|
| Serebryakova T.N., Sharkova T.S., Podorolskaya L.V., Neumivakin L.V., Khromov I.S., Khokhlov N.V., Agniullin J.V., Tarantul V.Z. |
| |
|
EXPLORING ADULT PATIENT POPULATIONS AT RISK FOR DEVELOPING HIT
|
| Dager W., Lee A., Gosselin R.C., King J., Wun T., Janatpour K., Owings J., White R. |
| |
|
EXPOSED MANNOSYLATION ON THERAPEUTIC FACTOR VIII MEDIATES ITS ENDOCYTOSIS BY HUMAN DENDRITIC CELLS LEADING TO ACTIVATION OF CD4+ T LYMPHOCYTES
|
| Dasgupta S., Navarrete A., Delignat S., Repesse Y., Andre S., Bayry J., Kaveri S.V., Lacroix-Desmazes S. |
| |
|
EXPOSURE-CLINICAL OUTCOME MODELING AND SIMULATION TO FACILITATE DOSE SELECTION OF APIXABAN IN SUBJECTS UNDERGOING ELECTIVE TOTAL KNEE REPLACEMENT SURGERY
|
| Feng Y., Li L.Y., Shenker A., Pfister M., Yu Z. |
| |
|
EXPRESSION AND CHARACTERISATION OF 4 ADAMTS13 MUTATIONS IDENTIFIED IN PATIENTS WITH TTP (UPSHAW-SCHULMAN SYNDROME)
|
| Hommais A., Rayes J., Houllier A., Obert B., Legendre P., Veyradier A., Girma J., Ribba A. |
| |
|
EXPRESSION AND SECRETION OF ADAMTS13 IS INHIBITED BY PROINFLAMMATORY STIMULATION
|
| Claus R.A., Bockmeyer C.L., Conradi F., Sieber M.W., Bauer M., Lösche W. |
| |
|
EXPRESSION OF MT1-MMP IN HUMAN VASCULAR ENDOTHELIAL CELL LINES AND THE CONSTRUCTION OF ITS EUKARYOTIC EXPRESSION VECTOR
|
| Jiang J., Hu X., Ma Z., Dong N., Bai X., Ruan C. |
| |
|
EXPRESSION OF PROTEIN DISULFIDE ISOMERASE DURING THROMBUS FORMATION
|
| Cho J., Furie B.C., Furie B. |
| |
|
EXPRESSION OF THE TFPI V264M MUTANT IN VASCULAR CELL CULTURES INVOLVES STABILITY OF MRNA
|
| Skretting G., Lien T., Andersen T.O., Sandset P.M., Iversen N. |
| |
|
EXPRESSION OF TISSUE FACTOR (TF), FACTOR X, PROTHROMBIN FRAGMENT 1+2 (F 1+2) AND FIBRIN IN BREAST CANCER: COMPARISON BETWEEN PRIMARY TUMOR AND METASTATIC LESIONS IN REGIONAL LYMPH NODES
|
| Wojtukiewicz M.Z., Sierko E., Sawicki Z., Zimnoch L., Kisiel W. |
| |
|
EXPRESSION PATTERN OF PROTEIN S AND GAS6 IN THE RETINA
|
| Lara R., Gaillard F., Cousin L., Girard N., Monvoisin A., Voisin P., Benzakour O. |
| |
|
EXTERNAL QUALITY CONTROL FOR THE COAGUCHEK INR MEASUREMENT IMPORTANT TO CONTROL TEST STRIP QUALITY: EVIDENCE FOR LIMITED PROPORTIONAL DIFFERENCES
|
| Meijer P., Kluft C., Poller L., van der Meer F., Keown M., Ibrahim S., van den Besselaar T., Tripodi A., Jespersen J. |
| |
|
EXTRA- AND INTRA-REACTIVE CENTRE LOOP ALTERATIONS TO ALPHA-1-PROTEINASE INHIBITOR ENHANCE ITS SPECIFIC INHIBITION OF THROMBIN
|
| Sutherland J.S., Bhakta V., Sheffield W.P. |
| |
|
EXTRACTS OF AN EDIBLE MUSHROOM WITH ANTITHROMBIN III-INDEPENDENT ANTICOAGULANT ACTIVITY
|
| Akahane K., Satoh K., Inoue O., Inoue K., Takei R., Ozaki Y. |
| |
|
EXTREMITY NEOPLASM IN PATIENTS WITH HAEMOPHILIA: EXPERIENCE IN MANAGING AN ADOLESCENT WITH MULTICENTRIC GIANT CELL TUMORS
|
| Chang C.C., Chang S.T. |
| |
